Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Back

Showing results (11-20 of 99) with videos related to

Pageof 10
Sort By:
The Journal of Antimicrobial Chemotherapy|March 22, 2013
Predicting intestinal absorption of raltegravir using a population-based ADME simulationDarren M Moss, Marco Siccardi, David J Back, et al.
Pharmacogenetics and Genomics|June 14, 2013
RXRγ gene variants are associated with HIV lipodystrophySudeep P Pushpakom, Andrew Owen, David J Back, et al.
Antiviral Therapy|December 14, 2011
Pharmacokinetics of antiretroviral drugs in anatomical sanctuary sites: the male and female genital tractLaura J Else, Stephen Taylor, David J Back, et al.
Antiviral Therapy|December 14, 2011
Pharmacokinetics of antiretroviral drugs in anatomical sanctuary sites: the fetal compartment (placenta and amniotic fluid)Laura J Else, Stephen Taylor, David J Back, et al.
The Journal of Antimicrobial Chemotherapy|November 18, 2021
Dexamethasone is a dose-dependent perpetrator of drug-drug interactions: implications for use in people living with HIVTom G Jacobs, Catia Marzolini, David J Back, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 2, 2005
The pharmacology of antiretroviral nucleoside and nucleotide reverse transcriptase inhibitors: implications for once-daily dosingDavid J Back, David M Burger, Charles W Flexner, et al.
Antimicrobial Agents and Chemotherapy|September 25, 2013
Induction of influx and efflux transporters and cytochrome P450 3A4 in primary human hepatocytes by rifampin, rifabutin, and rifapentineBeth Williamson, Kelly E Dooley, Yuan Zhang, et al.
Clinical Pharmacokinetics|April 8, 2021
Pharmacokinetics and Drug-Drug Interactions of Long-Acting Intramuscular Cabotegravir and RilpivirineDaryl Hodge, David J Back, Sara Gibbons, et al.
AIDS (London, England)|June 27, 2008
Effect of atazanavir and ritonavir on the differentiation and adipokine secretion of human subcutaneous and omental preadipocytesSimon P Jones, Catriona Waitt, Robert Sutton, et al.
British Journal of Pharmacology|December 18, 2009
The accumulation and metabolism of zidovudine in 3T3-F442A pre-adipocytesOmar Janneh, Andrew Owen, Patrick G Bray, et al.
Pageof 10

Showing results (11-20 of 99) with videos related to

Sort By:
Pageof 10
The Journal of Antimicrobial Chemotherapy|March 22, 2013
Predicting intestinal absorption of raltegravir using a population-based ADME simulationDarren M Moss, Marco Siccardi, David J Back, et al.
Pharmacogenetics and Genomics|June 14, 2013
RXRγ gene variants are associated with HIV lipodystrophySudeep P Pushpakom, Andrew Owen, David J Back, et al.
Antiviral Therapy|December 14, 2011
Pharmacokinetics of antiretroviral drugs in anatomical sanctuary sites: the male and female genital tractLaura J Else, Stephen Taylor, David J Back, et al.
Antiviral Therapy|December 14, 2011
Pharmacokinetics of antiretroviral drugs in anatomical sanctuary sites: the fetal compartment (placenta and amniotic fluid)Laura J Else, Stephen Taylor, David J Back, et al.
The Journal of Antimicrobial Chemotherapy|November 18, 2021
Dexamethasone is a dose-dependent perpetrator of drug-drug interactions: implications for use in people living with HIVTom G Jacobs, Catia Marzolini, David J Back, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 2, 2005
The pharmacology of antiretroviral nucleoside and nucleotide reverse transcriptase inhibitors: implications for once-daily dosingDavid J Back, David M Burger, Charles W Flexner, et al.
Antimicrobial Agents and Chemotherapy|September 25, 2013
Induction of influx and efflux transporters and cytochrome P450 3A4 in primary human hepatocytes by rifampin, rifabutin, and rifapentineBeth Williamson, Kelly E Dooley, Yuan Zhang, et al.
Clinical Pharmacokinetics|April 8, 2021
Pharmacokinetics and Drug-Drug Interactions of Long-Acting Intramuscular Cabotegravir and RilpivirineDaryl Hodge, David J Back, Sara Gibbons, et al.
AIDS (London, England)|June 27, 2008
Effect of atazanavir and ritonavir on the differentiation and adipokine secretion of human subcutaneous and omental preadipocytesSimon P Jones, Catriona Waitt, Robert Sutton, et al.
British Journal of Pharmacology|December 18, 2009
The accumulation and metabolism of zidovudine in 3T3-F442A pre-adipocytesOmar Janneh, Andrew Owen, Patrick G Bray, et al.
Pageof 10